Natural biochemical systems are ubiquitously organized both in space and time. 16
Introduction 32
Synthetic biology traces its origins to the discovery of type II restriction endonucleases 33 (Kelly and Smith, 1970; Smith and Welcox, 1970) . These enzymes allowed the 34 controlled assembly of novel genes, plasmids, and other nucleic acids, and precipitated 35 the rapid spread of molecular cloning technology. Since then, synthetic biology has 36 sought to exploit, adapt, and extend biological systems to benefit society by creating 37 pharmaceuticals, fuels, gene therapies, drug delivery platforms, probiotics, and more. 38
Metabolic engineering, the use of microbes to produce small and large molecules of 39 commercial and scientific interest, has been a particular focus. To this end, synthetic 40 biologists have developed methods to control transcription and translation, knock out 41 native genes to route metabolic flux down desired channels, integrate multiple chemical 42 and physical inputs to make decisions inside microbial cells, and make wholesale 43 changes to the genomes of organisms in high throughput. computationally design composable genetic circuits based on these parts with high 59 fidelity (Nielsen et al., 2016; Roehner et al., 2016) . Efforts were also made to understand 60 and control translation elongation, and inform the choice of codons in heterologous genes 61 (Goodman et al., 2013) . 62
63
Along with the introduction of foreign genes into microbial factories, it was soon 64 recognized that removing host genes was also of critical importance. Sophisticated 65 computational approaches now exist to predict which native genes should be removed 66 from a microbe in order to maximize the yield of a desired biosynthetic product (Burgard also include predictions of host or foreign genes whose introduction might be beneficial 69 (Ranganathan et al., 2010; Srivastava et al., 2012) . 70 71 Cellular computation, enabling cells to collect information from their environment and 72 make decisions accordingly, has also been an important focus of synthetic biology 73 (Purcell and Lu, 2014 ), but will not be discussed further here. Instead we will focus on 74 metabolic engineering applications. 75 76 Despite all of these technological advances, there have been relatively few examples of 77 the commercially successful, industrial scale production of chemicals by microbes 78 (Lechner et al., 2016) . Notable successes have included artemisinic acid (Paddon et al., 79 2013), as well as farnesene, 1,3-propanediol, and 1,4-butanediol (Lechner et al., 2016) , 80 but, by and large, the biological production of chemicals at industrially viable titers has 81 remained elusive. This is most often due to one (or more) of five ubiquitous roadblocks to 82 biosynthesis: cellular toxicity due to accumulation of intermediates of the biosynthetic 83 pathway; the loss of flux to undesired byproducts; difficulties sustaining sufficient 84 substrate influx; leakage and loss of intermediates into the culture medium; and trapping 85 of product in the host cell due to inadequate efflux [ Fig. 1A ]. 86
87
A new wave of synthetic biology technologies aims to address these key issues using a 88 diverse array of strategies, while also preparing to deploy engineered microbes widely 89 and safely. These cutting-edge approaches include cell-free approaches to protein and 90 small molecule synthesis ( Here, we will analyze one class of these strategies: the spatial organization of metabolism 103 within cells [ Fig. 1B ] . There are a wide variety of natural methods for 104 spatial organization (Agapakis et al., 2012) . Eukarya discretize their biochemistry into 105 highly chemically distinct subcellular compartments and into enzyme complexes such as 106 polyketide synthases (Khosla et al., 2014) and other metabolons (Wu and Minteer, 2014) . 107
Bacteria, too, are now understood to organize their metabolism in a variety of ways, 108 including using protein-based carboxysomes (Shively et al., 1973) , microcompartments 109 Pathway encapsulation in bacterial microcompartments can provide benefits comparable 159 to protein engineering 160
We will outline the potential metabolic engineering benefits that could be derived from 161 pathway organization using two different strategies: encapsulation in the Pdu 162 microcompartment of Salmonella and other enteric bacteria, and organization using a To instead model a scaffolded system, we simply assume that the enzymes in question 176 are localized to a volume equivalent to that occupied by the Pdu microcompartments, but 177 without a diffusion barrier. This is represented mathematically by setting the velocity of 178 transport between the scaffold volume and the cytosol equal to that predicted by free 179 diffusion. The model formulation we use here is agnostic to the underlying scaffolding 180 platform (protein, lipid, or nucleic acid) or its microscopic organization, as we assume a 181 well-mixed scaffold volume. 182
183
We predict the consequences of organization using these two strategies for two model 184 biochemical processes: native Pdu microcompartment metabolism and the heterologous 185 mevalonate biosynthetic pathway. The compounds and enzyme kinetic parameters for 186 each pathway are in Figure 2AB . We adapt the modeling approach used for the native 187 this assumption, we find that the concentration gradient in the cytosol is small across a 198 wide range of external substrate concentrations for all the organizational cases we tested 199
We first ask: is organization worth the time and trouble for the metabolic engineer to 202 arrange, as compared to traditional metabolic and enzyme engineering strategies (such as 203 improvements to the k cat or K M kinetic parameters)? Here, we use the native Pdu 204 microcompartment pathway as an example. If, for instance, engineering efforts increased 205 the k cat of each of the two key enzymatic steps 100-fold, or decrease the K M of each key 206 step 100-fold, the improvement in flux would be as shown in Figure 2CD (as compared 207 to the native system with no organization). Improvements of this magnitude for both 208 enzymes represent a significant technical challenge and would be non-trivial to achieve 209 for an arbitrary enzymatic system. We predict that encapsulation of native Pdu 210 metabolism in an organelle is practically as effective as large improvements in k cat , and 211 more effective than large improvements in K M , with respect to increasing the total flux organizational strategy to maximize flux as a function of both variables, with the optimal 263 strategy indicated by the color of the phase space at that parameter value combination. 264
For reference, the dashed line in each panel of Figure 3C indicates the k cat E 0 value used to 265 construct the one-dimensional representations with respect to S ext in Figure 3A Finally, we demonstrate how the optimal organizational strategy changes as a function of 281 two intrinsic pathway properties (rather than one intrinsic and one extrinsic property, as 282 in Fig. 3C ). While there are many parameters that can change between pathways, we 283 focus on two key differences between the Pdu MCP system and mevalonate pathway. 284
The values we estimate for the cell membrane permeability to the intermediate and k cat E 0 285 for the second enzyme differ by approximately two orders of magnitude between the two 286 systems. We therefore predicted the optimal organizational strategy as a function of these 287 two parameters, and indicated the location of each enzyme system in this phase space 288 determining the optimal organization strategy for a given pathway, and can weigh the 306 ease of altering a given parameter against the potential rewards in terms of engineering 307 goals like pathway flux. 308
309
Enzyme stoichiometry and kinetics, as well as design goals, influence optimal 310 organization strategy 311
We can address the question of organization choice more generally by examining the 312 relative performance of three strategies (free cytosolic localization of enzymes; scaffolds; 313 and microcompartments) across a wide range of enzyme kinetic parameters. Considering, 314
for instance, the two-enzyme pathway of native Pdu metabolism, we can predict the 315 optimal strategy as we vary the activity (k cat E 0 ) of each enzyme [ Fig. 4A ]. This variation 316 can represent either the Pdu enzymes or a different enzymatic pathway. In this example, 317 microcompartment organization is favored with respect to maximizing pathway flux 318 unless the respective k cat E 0 parameters for both enzymes are sufficiently large to render 319 the effect of concentrating intermediate species in the microcompartment insignificant, in 320 which case a scaffold is recommended. Conversely, for small k cat E 0 of both enzymes, a 321 strategy without spatial organization is indicated to minimize intermediate loss [ Fig. 4A ]. 322
These phase space predictions of organization performance can be made for arbitrary 323 organizational strategies and metabolic pathways, given appropriate kinetic models. Above, we outline the potential for the spatial organization of heterologous pathways to 369 greatly enhance their performance. This approach compares well with traditional enzyme 370 engineering approaches. Furthermore, we describe a general framework to guide the 371 choice of appropriate organizational strategies for metabolic engineering. Several key 372 parameters must be accounted for: (I) enzyme kinetics; (II) substrate and intermediate 373 chemical properties; and (III) external culture conditions. Some of these properties, such 374 as the external substrate concentration and the transport properties of the cell membrane, 375
can influence the supply of substrate to the pathway, while others, such as the presence or 376 absence of competing reactions and the transport properties of the organelle boundary, 377
can influence the loss of metabolic flux to off-target species. We outline the use of a 378 general modeling approach to analyze the performance of different organization 379 strategies, and present example organizational recommendations. Moreover, modeling 380 approaches can suggest key experiments (e.g. variations of external substrate 381 concentration) that may reveal important discrepancies in the performance of different 382 organization strategies. The MATLAB code used to generate the graphics in this 383 manuscript is freely available on GitHub (URL TBD), and we encourage members of the 384 metabolic engineering and synthetic biology communities to explore the organizational 385 performance landscapes for their own systems of interest. We also welcome suggestions 386 of other useful kinetic or organizational regimes to include in future versions of the 387 model. 388
389
Avenues to improve understanding and prediction of optimal spatial organization 390
The framework above can provide important insights into the choice of optimal 391 organizational strategies for heterologous pathways, but several important aspects of 392 pathway organization remain unexplored. These include product export, cell size and 393 morphology, competitive reactions, and the detailed organization of the organelles or 394 scaffolds within the host cell. The organization of organelles within cells has been 395 investigated in the context of a constant cytosolic metabolite concentration (Hinzpeter et 396 al., 2017) , and future efforts could combine this and our approaches. 397
398
Our model as currently implemented can incorporate extensions to explore some of these 399 areas, but some questions, notably the effect of competitive cellular reactions and 400 reactions upstream of the organized process, will require the integration of our model 401 with larger-scale metabolic models of host processes. Exploring the effect of the detailed 402 subcellular localization of the organizing structures themselves will likewise require 403 modifications to our current mathematical framework. 404
405
Practical engineering considerations 406
Within the framework described here, we evaluate only the pathway flux and 407 intermediate leakage predicted for each potential organization strategy, neglecting the 408 difficulty associated with engineering a particular strategy. It may transpire that, for 409 certain pathways, scaffolding proves challenging to implement due to incompatibilities 410 between the requisite protein tags and the enzymes in question, or that the pores of 411 microcompartment shells are fundamentally of low permeability to the substrates of other 412 pathways. Practical experience with these issues will continue to inform the choice of 413 appropriate strategies, and may eventually allow the integration of such practical as well 414 as theoretical considerations into objective functions. We expect that some key 415 experiments, such as assays to quantitatively determine the permeability of protein shells 416 to small molecules, will greatly enhance the predictability of engineering pathways in 417 microcompartments. 418
Closing thoughts 420
Organizing biochemistry in both time and space holds tremendous potential to help 421 deliver on the promise of synthetic biology: the ability to produce medically and 422 industrially important molecules at high yield and high titer with minimal environmental 423 disruption. Spatial organization of the kind we advocate is but one of many important 424 approaches; techniques to use multiple (or no) cells, to detect and transport metabolites, 425
and to exert dynamic control on short time scales are of critical importance, as well. We 426 posit that detailed mechanistic models of each of these approaches will be key in building 427 a fundamental theoretical understanding of the optimal strategies to improve the 428 performance of arbitrary biosyntheses. 429
Materials and Methods 430

Contact for resource and reagent sharing 431
For questions and further information regarding software and models used herein, please 432 contact NMM (niallmm@gmail.com). 433 434
Method details 435
Model 436
The reaction-diffusion model framework used herein is substantially the same as that 437 described in Jakobson, et al., PLoS Computational Biology, 2017 , in which we explored 438 the native function of the Pdu MCP system in S. enterica. The analytical and numerical 439 approach is described in detail in that manuscript, but the important assumptions can be 440 summarized as follows: 441 442 1. We assume a spherically symmetrical organelle or scaffold at the center of a 443 spherically symmetrical cell. 444 2. We consider the system at steady-state. where 457
and 458 R 2 = V 2 S 2 (r) K 2 + S 2 (r)
459
In the case of organelle-or scaffold-based organization, a closed-form analytical solution 460
to the governing equations can be found, provided we assume that the metabolite 461 concentration inside the organelle or scaffold region is constant. This solution is used to 462 generate the various figures comparing organization strategies; see Jakobson et al., 2017 463 for the derivation and complete analytical solutions. A scaffold-like behavior is created 464 by setting the permeability at the organelle boundary to approximate free diffusion (that 465 is, k c S1 = k c S2 ~ 10 3 ). In the case with no organization, we instead use a numerical 466 solution, as the analytical solution does not hold in this regime. The numerical solution at 467 steady state is generated by a finite difference routine implemented in MATLAB; again 468 see Jakobson et al., 2017 for more details on the governing equations and boundary 469 conditions used in the numerical routine. 470
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